LRCX vs MNOV · P/E 71, rev $23.23B vs rev $645.4K
Lam Research Corp (LRCX) versus MediciNova Inc (MNOV) — a side-by-side from cached financials, not a winner call.
Lam Research Corp (LRCX) is a semiconductor equipment & materials company listed on NASDAQ. It is led by Timothy M. Archer.
MediciNova Inc (MNOV) is a biotechnology company listed on NASDAQ.
Latest reported LRCX revenue for 2026-06-28 was $23.23B. Net income was $7.27B. LRCX currently screens at market cap $467.94B and trailing P/E 70.9.
Latest reported MNOV revenue for 2026-06-30 was $645.4K. Net income was -$4.9M. MNOV currently screens at market cap $66.0M.
LRCX currently screens at market cap $467.94B and trailing P/E 70.9. MNOV currently screens at market cap $66.0M.
Not investment advice. Open the LRCX and MNOV stock pages for the full models.
Not investment advice.